Kim A. Rivers - 08 Mar 2024 Form 4 Insider Report for Trulieve Cannabis Corp. (TCNNF)

Signature
/s/ Eric Powers, as Attorney-in-Fact
Issuer symbol
TCNNF
Transactions as of
08 Mar 2024
Net transactions value
$0
Form type
4
Filing time
12 Mar 2024, 20:35:02 UTC
Previous filing
16 Jan 2024
Next filing
17 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRUL Subordinate Voting Shares Award $0 +127,500 +4.8% $0.000000 2,804,461 08 Mar 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRUL Stock Option (Right to Buy) Award $0 +230,868 $0.000000 230,868 08 Mar 2024 Subordinate Voting Shares 230,868 $10.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2025, and the remaining 50% of the RSUs will vest on December 1, 2026.
F2 The reporting person also holds the following securities of the issuer: (i) 159,867 aggregate Multiple Voting Shares held directly, (ii) 9,867 Multiple Voting Shares held by Traunch IV LLC ("Traunch IV"), over which the reporting person may be deemed to exercise voting and investment control, and (iii) stock options to acquire 649,559 Subordinate Voting Shares vested as of January 1, 2024 held directly. Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis (or into an aggregate of 16,973,400 Subordinate Voting Shares). The reporting person disclaims beneficial ownership of the Multiple Voting Shares (and the Subordinate Voting Shares into which they are convertible) held by Traunch IV, except to the extent of her pecuniary interest therein.
F3 The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2024, one-third vesting on December 1, 2025, and one-third vesting on December 1, 2026.